Antipsychotics associated with weight gain, lower levels of good cholesterol in Alzheimer's patients

Share this article:
Two newer antipsychotic drugs have negative side effects in Alzheimer's patients. Both promote weight gain and one lowers levels of HDL "good" cholesterol, according to a new study.

The drugs associated with weight gain are olanzapine and quetiapine. Those who took olanzapine showed both weight gain and declines in HDL cholesterol. The study was to be published online April 15 in the American Journal of Psychiatry.

"These findings are especially troubling, because antipsychotics are associated with a higher risk of death and cerebrovascular adverse events in patients with dementia," according to principal investigator Dr. Lon S. Schneider in an American Psychiatric Association news release. "They're often used to minimize disruptive symptoms (such as psychosis or agitation), but patients should be monitored more closely."

Share this article:

More in News

A small team of workers responds best in emergencies, expert says

A small team of workers responds best in ...

Long-term care providers should consider a "flat" crisis management approach that relies on a core group of staff members, experts advised Wednesday at the LeadingAge annual conference.

Nursing homes have better pain and catheter management if leaders have more ...

Nursing homes led by administrators and directors of nursing with higher levels of education and certification have better outcomes on some key quality measures, according to recently published findings.

Court green-lights charges that a healthcare network underused observation stays

A whistleblower can continue to pursue charges that a Nevada healthcare network routinely admitted people as hospital inpatients when they should have been placed in observation status, a federal appeals court recently ruled.